Sponsored Links
| FDA Approves Roche's HPV Test For Identifying Women At Highest Risk For Cervical Cancer |
 |
 |
 |
| Medical News - Cervical Cancer HPV | |||
|
Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the U.S. Food and Drug Administration (FDA) has approved the cobas HPV (Human Papillomavirus) Test which identifies women at highest risk for developing cervical cancer. This test will help physicians make early, more accurate decisions about patient care, which may prevent many women from developing this deadly disease... Read more: Cervical Cancer / HPV Vaccine News From Medical News Today
|